Article
Mechanism of dual pharmacological correction and potentiation of human CFTR
2022-10-11
Abstract excerpt
<h4>ABSTRACT</h4> Cystic fibrosis (CF) is caused by mutations in a chloride channel called the human Cystic Fibrosis Transmembrane Conductance Regulator (hCFTR). We used cryo-EM global conformational ensemble reconstruction to characterize the mechanism by which the breakthrough drug VX445 (Elexacaftor) simultaneously corrects both protein-folding and channel-gating defects caused by CF mutations. VX445 drives hC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 24ebe7b4-1a59-5789-acf3-9b8622f4d981
- DOI
- 10.1101/2022.10.10.510913
